Bruker Corporation Profile Avatar - Palmy Investing

Bruker Corporation

Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Sci…

Medical - Devices
US, Billerica [HQ]

Ratios

15 Records · Starting from 2009
Margins, Growth Rates In %
Ratio 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Profitability
Gross Margin
46.53 46.44 45.56 46.41 43.78 42.20 43.64 46.08 46.04 47.48 48.02 47.29 50.03 51.59 51.17
Profit Margin
7.29 7.31 5.59 4.33 4.35 3.13 6.26 9.53 4.45 9.48 9.51 7.94 11.46 11.72 14.41
Operating Margin
12.27 11.93 9.42 8.71 8.06 5.83 8.97 11.00 12.16 13.84 14.52 12.49 17.09 17.10 16.27
EPS Growth
25.00 16.00 -3.45 -16.07 2.13 -29.17 76.47 58.33 -47.37 130.00 10.44 -18.90 77.67 9.29 46.00
Return on Assets (ROA)
6.93 6.16 5.40 4.17 4.03 3.04 5.87 8.47 4.03 8.44 7.12 5.18 7.59 8.20 10.05
Return on Equity (ROE)
19.39 18.09 14.77 10.97 9.42 7.35 13.86 22.16 10.72 19.85 21.50 16.17 25.55 26.35 31.02
Return on Invested Capital (ROIC)
15.41 12.12 10.83 8.45 8.07 5.50 11.95 13.95 7.59 15.57 11.95 9.51 12.18 13.26 14.18
Solvency
Equity Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Debt/Assets
11.75 19.42 17.72 18.16 17.85 19.04 15.41 22.71 21.33 16.03 31.04 29.25 36.55 33.69 30.33
Debt/Equity
32.88 57.07 48.50 47.72 41.76 46.00 36.39 59.40 56.66 37.69 93.81 91.38 123.01 108.31 93.60
Debt/EBITDA
-17.46 43.72 36.00 12.23 -35.15 16.96 -0.18 26.93 30.37 5.39 47.52 59.30 51.48 104.23 149.25
Debt/Capitalization
24.74 36.34 32.66 32.31 29.46 31.51 26.68 37.26 36.17 27.37 48.40 47.75 55.16 51.99 48.35
Interest Debt per Share USD
0.89 1.86 1.88 2.12 2.21 2.19 1.66 2.63 2.73 2.26 5.65 5.91 8.91 8.31 8.92
Debt Growth
-38.47 118.59 0.70 11.25 5.28 - - -24.87 54.37 0.95 -17.93 152.21 3.63 49.66 -8.62 13.16
Liquidity
Current Ratio
162.03 126.41 157.99 192.07 220.77 234.48 222.07 242.02 259.07 218.11 278.24 242.55 263.38 232.49 180.03
Quick Ratio
72.57 55.72 69.97 87.97 115.06 135.70 126.76 141.51 144.61 113.65 162.19 134.46 168.90 133.31 93.34
Cash Ratio
38.42 27.71 32.55 45.55 67.64 54.83 48.16 65.11 61.96 53.91 105.07 85.91 113.82 70.64 40.62
Operating Cash Flow Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Turnover
Inventory Turnover
140.94 136.77 156.06 156.99 175.35 219.02 216.87 197.28 195.99 195.37 186.64 151.34 170.16 152.42 149.51
Receivables Turnover
605.38 560.28 584.05 619.22 597.98 616.95 691.86 660.64 553.05 530.68 572.23 592.75 579.97 535.37 476.76
Payables Turnover
1,196.59 1,092.03 263.77 1,379.31 1,382.62 1,375.79 1,269.35 1,009.06 1,049.45 952.73 909.88 778.38 819.74 671.97 714.21
Asset Turnover
95.09 84.20 96.56 96.50 92.51 97.00 93.81 88.88 90.63 89.05 74.78 65.21 66.24 69.94 69.75
Coverage
Interest Coverage
1,822.67 2,780.36 2,131.51 1,090.91 1,105.97 792.48 1,120.77 1,342.42 1,394.16 2,082.54 1,880.62 1,724.31 2,890.21 2,687.58 2,940.85
Asset Coverage
400 200 200 200 300 200 300 200 200 200 100 200 100 200 200
Cash Flow Coverage (CFGR)
108.79 51.86 28.93 39.47 40.85 32.20 85.94 31.77 37.15 70.27 24.81 37.38 21.17 21.49 27.16
EBITDA Coverage
5,300 2,800 2,100 1,500 1,700 1,500 1,700 1,900 1,900 2,700 2,300 2,400 3,600 3,400 3,600
Dividend Coverage
- - -95,400 - - - - - - - - - - -500 -300 -700 -700 -600 -1,100 -900 -1,400
Time Interest Earned (TIE)
200 100 100 100 100 100 100 100 100 100 100 100 100 100 100
Market Prospects
Dividend Yield
- - - - - - - - - - - - - - 0.75 0.47 0.54 0.32 0.30 0.19 0.29 0.27
Earnings Yield
4.12 3.50 4.49 3.06 2.43 1.72 2.49 4.49 1.45 3.86 2.49 1.90 2.18 2.92 3.97
Price/Earnings (P/E)
24.2834 28.6063 22.2564 32.6431 41.0949 58.0641 40.1793 22.2555 69.0330 25.8769 40.1143 52.6207 45.8462 34.2441 25.1813
Price/Book (P/B)
470.82 517.45 328.74 358.03 387.17 426.62 556.99 493.21 739.74 513.76 862.56 851.12 1,171.30 902.27 781.11
Price/Sales (P/S)
176.92 209.14 124.37 141.22 178.96 182.00 251.40 212.15 307.26 245.31 381.67 417.79 525.41 401.34 362.88
Price/Cash Flow (P/CF)
1,316.30 1,748.26 2,342.38 1,900.71 2,270.14 2,880.35 1,781.07 2,613.50 3,514.24 1,939.96 3,706.91 2,492.06 4,498.57 3,876.65 3,072.69
End of BRKR's Analysis
CIK: 1109354 CUSIP: 116794108 ISIN: US1167941087 LEI: - UEI: -
Secondary Listings
BRKR has no secondary listings inside our databases.